Esophageal adenocarcinoma: risk factors and modern screening strategy

Esophageal adenocarcinoma: risk factors and modern screening strategy

Aim of review. To present the modern concepts on epidemiological pattern and risk factors of esophageal adenocarcinoma (EAC) and analyze the modern screening approach. Summary. In developed countries EAC is characterized by rapid increase of mobidity, as well as by high mortality level. As a rule, E...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. V. Mayev, D. N. Andreyev, Yu. A. Kucheryavy, M. P. Scheglanova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	аденокарцинома пищевода гастроэзофагеальная рефлюксная болезнь пищевод баррета скрининг
Online Access:	https://www.gastro-j.ru/jour/article/view/129
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microbiome in development of esophageal diseases
by: Yu. V. Yevsyutina, et al.
Published: (2016-08-01)

Modern options of prokinetics in gastroesophageal reflux disease treatment
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
by: Yu. V. Yevsyutina
Published: (2018-08-01)

High-resolution manometry in clinical practice: analysis of esophageal motor function according to Chicago classification
by: O. A. Storonova, et al.
Published: (2018-08-01)

Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Pleiotropic effects of rabeprazole at acid-related diseases
by: A. V. Zaborovsky, et al.
Published: (2018-08-01)

Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Treatment compliance of patients with gastro-intestinal diseases
by: O. P. Alekseyeva, et al.
Published: (2016-08-01)

Clinical impact of 24-hour pH-metry in esophageal and stomach diseases diagnostics and pharmacological drugs efficacy testing
by: A. S. Trukhmanov, et al.
Published: (2018-08-01)

Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
by: V. I. Simanenkov, et al.
Published: (2018-08-01)

Functional heartburn and reflux hypersensitivity syndrome (according to the Rome-IV functional esophageal disease diagnostic criteria)
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Postcholecystectomy syndrome: the modern approach: resolution of Advisory council
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Diagnostics and treatment of cardiac achalasia and cardiospasm: guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Peptic ulcer: does it changed identity?
by: Ye. A. Pyatenko, et al.
Published: (2018-08-01)

The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma
by: O. A. Storonova, et al.
Published: (2024-08-01)

The effect of maintenance therapy on Crohn’s disease clinical outcomes
by: O. B. Schukina, et al.
Published: (2018-08-01)

Clinical round: 27 year old patient with initially diagnosed Crohn's disease and severe protein and energy deficiency
by: V. S. Scherbakha, et al.
Published: (2018-08-01)

Features of pathogenesis, diagnostics and treatment of gallstone disease at pregnancy
by: Yu. B. Uspenskaya, et al.
Published: (2018-08-01)

Successful endoscopic treatment of diverticular disease complicated by paracolic abscess
by: A. I. Khripun, et al.
Published: (2018-08-01)

Treatment compliance of liver cirrhosis patients
by: Ye. R. Olevskaya, et al.
Published: (2018-08-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

The important practical results and modern lines in studying diseases of the stomach and duodenum (Review of the Seventeenth Russian Gastroenterological Week proceedings, October, 10–12, 2011, Moscow)
by: I. V. Mayev, et al.
Published: (2012-07-01)

Surgical treatment of the fistulizing Crohn's disease with anterior abdominal wall reconstruction (Clinical case)
by: Yu. Ye. Kitsenko, et al.
Published: (2018-08-01)

Efficacy of Esophageal Protector in Treating Gastroesophageal Reflux Disease with Extraesophageal Symptoms: a Multicenter, Open-Label, Observational Study
by: Yu. A. Kucheryavy, et al.
Published: (2022-12-01)

Noninvasive markers of inflammatory bowel disease activity
by: A. V. Nikitin, et al.
Published: (2018-08-01)

Chronic inflammatory bowel diseases: the course and treatment methods in Russian Federation (Results of multicenter population-based one-stage observational study)
by: L. . Khalif, et al.
Published: (2018-08-01)

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
by: I. G. Bakulin, et al.
Published: (2018-08-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
by: T. P. Rozina, et al.
Published: (2018-08-01)

Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Population features of prevalence and clinical-diagnostic role of NOD2 gene polymorphisms associated with Crohn’s disease
by: D. A. Kuznetsova, et al.
Published: (2018-08-01)

Периоперационное кондиционирование оксидом азота для предотвращения острого почечного повреждения при кардиохирургических вмешательствах у пациентов с хронической болезнью почек: промежуточные результаты рандомизированного контролируемого исследования DEF
by: Николай Олегович Каменщиков, et al.
Published: (2024-11-01)

Hexapeptide dalargin in clinical gastroenterology: 30 years' of clinical application of the drug
by: S. A. Bulgakov
Published: (2016-08-01)

Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Improvement of Helicobacter pylori eradication efficacy at stomach and duodenum peptic ulcers
by: Natalya O. Schanova, et al.
Published: (2016-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
by: P. V. Tsarkov, et al.
Published: (2018-08-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Extraintestinal manifestations of inflammatory bowel diseases: arthropathy and arthritis
by: Gulustan Hamid Sadygova
Published: (2018-08-01)